Background And Objective: Fluorescence molecular tomography (FMT) is a non-invasive molecular imaging modality that can be used to observe the three-dimensional distribution of fluorescent probes in vivo. FMT is a promising imaging technique in clinical and preclinical research that has attracted significant attention. Numerous regularization based reconstruction algorithms have been proposed. However, traditional algorithms that use the squared l-norm distance usually exaggerate the influence of noise and measurement and calculation errors, and their robustness cannot be guaranteed.
Methods: In this study, we propose a novel robust transformed l (TL1) metric that interpolates l and l norms through a nonnegative parameter α∈(0,+∞). The TL1 metric looks like the l-norm with p∈(0,1). These are markedly different because TL1 metric has two properties, boundedness and Lipschitz-continuity, which make the TL1 criterion suitable distance metric, particularly for robustness, owing to its stronger noise suppression. Subsequently, we apply the proposed metric to FMT and build a robust model to reduce the influence of noise. The nonconvexity of the proposed model made direct optimization difficult, and a continuous optimization method was developed to solve the model. The problem was converted into a difference in convex programming problem for the TL1 metric (DCATL1), and the corresponding algorithm converged linearly.
Results: Various numerical simulations and in vivo bead-implanted mouse experiments were conducted to verify the performance of the proposed method. The experimental results show that the DCATL1 algorithm is more robust than the state-of-the-art approaches and achieves better source localization and morphology recovery.
Conclusions: The in vivo experiments showed that DCATL1 can be used to visualize the distribution of fluorescent probes inside biological tissues and promote preclinical application in small animals, demonstrating the feasibility and effectiveness of the proposed method.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cmpb.2023.107503 | DOI Listing |
JCO Oncol Pract
December 2024
Department of Surgery, Endeavor Health, Evanston, IL.
Background: Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of morbidity and mortality in the United States. Frequent exacerbations result in higher use of emergency services and hospitalizations, leading to poor patient outcomes and high costs.
Objective: Demonstrate the feasibility of a multimodal, digitally enhanced remote monitoring, treatment, and tele-pulmonary rehabilitation intervention among patients with COPD.
Pharmacoepidemiol Drug Saf
October 2024
Division of Rheumatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
Purpose: Few studies have reported the agreement between medication information derived from ambulatory EHR data compared to administrative claims for high-cost specialty drugs. We used data from a national EHR-enabled registry, the Rheumatology Informatics System for Effectiveness (RISE), with linked Medicare claims in a population of patients with rheumatoid arthritis (RA) to investigate variations in agreement for different biologic disease-modifying agents (bDMARDs) between two data sources (RISE EHR data vs. Medicare claims), categorized by drug, route of administration, and patient insurance factors (dual eligibility).
View Article and Find Full Text PDFbioRxiv
September 2024
Yale University School of Medicine, Child Study Center.
J Gerontol A Biol Sci Med Sci
November 2024
Department of Medicine, University of Colorado Denver-Anschutz Medical Campus, Aurora, Colorado, USA.
Background: People with HIV (PWH) experience faster physical decline than those without HIV (PWoH), despite antiretroviral therapy. We compared skeletal muscle density and area and their relationship with physical function among PWH and PWoH.
Methods: Quantitative computed tomography scans were performed at the L4-L5 spinal region and the thigh to evaluate muscle groups in Multicenter AIDS Cohort Study participants at baseline.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!